UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hepatitis C Virus Genetic Variability and the Presence of NS5B Resistance-Associated Mutations as Natural Polymorphisms in Selected Genotypes Could Affect the Response to NS5B Inhibitors

Antimicrobial agents and chemotherapy, 2014-05, Vol.58 (5), p.2781-2797

2014

Volltextzugriff (PDF)

Two‐drug vs. three‐drug combinations for HIV‐1: Do we have enough data to make the switch?

HIV medicine, 2019-04, Vol.20 (S4), p.2-12

2019

Volltextzugriff (PDF)

Alarming rates of virological failure and HIV‐1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY‐study in Cameroon

HIV medicine, 2021-08, Vol.22 (7), p.567-580

2021

Volltextzugriff (PDF)

The Management of Geriatric and Frail HIV Patients. A 2017 Update from the Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic Clinical Management of HIV-1 Infected Persons

The Journal of Frailty & Aging, 2019-01, Vol.8 (1), p.10-16

2019

Volltextzugriff (PDF)

Managing Haemophilia for Life: 4th Haemophilia Global Summit

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-07, Vol.20 (s5), p.1-20

2014

Volltextzugriff (PDF)

Exploring nasopharyngeal microbiota profile in children affected by SARS-CoV-2 infection

Microbiology spectrum, 2024-03, Vol.12 (3), p.e0300923-e0300923

2024

Volltextzugriff (PDF)

Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice

Journal of medical virology, 2013-06, Vol.85 (6), p.996-1004

2013

Volltextzugriff (PDF)

Natural polymorphisms of HIV-1 subtype-C integrase coding region in a large group of ARV-naïve infected individuals

Infection, 2013-12, Vol.41 (6), p.1097-1102

2013

Volltextzugriff (PDF)

The use of human immunodeficiency virus resistance tests in clinical practice

Clinical microbiology and infection, 2010-10, Vol.16 (10), p.1511-1517

2010

Volltextzugriff (PDF)

Antiretrovirus Activity of a Novel Class of Acyclic Pyrimidine Nucleoside Phosphonates

Antimicrobial Agents and Chemotherapy, 2002-07, Vol.46 (7), p.2185-2193

2002

Volltextzugriff (PDF)

Prediction of response to antiretroviral therapy by human experts and by the EuResist data‐driven expert system (the EVE study)

HIV medicine, 2011-04, Vol.12 (4), p.211-218

2011

Volltextzugriff (PDF)

Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon

Archives of virology, 2011-07, Vol.156 (7), p.1235-1243

2011

Volltextzugriff (PDF)

Efficacy of etravirine combined with darunavir or other ritonavir‐boosted protease inhibitors in HIV‐1‐infected patients: an observational study using pooled European cohort data

HIV medicine, 2015-05, Vol.16 (5), p.297-306

2015

Volltextzugriff (PDF)

Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper

Clinical microbiology and infection, 2017-12, Vol.23 (12), p.935-940

2017

Volltextzugriff (PDF)

Human Immunodeficiency Virus-1 Viral Load Is Elevated in Individuals With Reverse-Transcriptase Mutation M184V/I During Virological Failure of First-Line Antiretroviral Therapy and Is Associated With Compensatory Mutation L74I

The Journal of infectious diseases, 2020-09, Vol.222 (7), p.1108-1116

2020

Volltextzugriff (PDF)

Virological response and resistance profile in HIV‐1‐infected patients starting darunavir‐containing regimens

HIV medicine, 2017-01, Vol.18 (1), p.21-32

2017

Volltextzugriff (PDF)

Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs

Antiviral research, 2011-11, Vol.92 (2), p.382-385

2011

Volltextzugriff (PDF)

Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individuals

Journal of clinical virology, 2023-11, Vol.168, p.105551-105551, Article 105551

2023

Volltextzugriff (PDF)

Relative Potency of Protease Inhibitors in Monocytes/Macrophages Acutely and Chronically Infected with Human Immunodeficiency Virus

The Journal of infectious diseases, 1998-08, Vol.178 (2), p.413-422

1998

Volltextzugriff (PDF)

HIV MDR is still a relevant issue despite its dramatic drop over the years

Journal of antimicrobial chemotherapy, 2020-05, Vol.75 (5), p.1301-1310

2020

Volltextzugriff (PDF)

Mechanism of Anti-HIV Action of Masked Alaninyl d4T-Mp Derivatives

Proceedings of the National Academy of Sciences - PNAS, 1996-07, Vol.93 (14), p.7295-7299

1996

Volltextzugriff (PDF)

1,2,3-Triazole-[2,5-Bis-O-(tert-butyldimethylsilyl)-.beta.-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole 2'',2''-dioxide) (TSAO) Analogs: Synthesis and Anti-HIV-1 Activity

Journal of medicinal chemistry, 1994-11, Vol.37 (24), p.4185-4194

1994

Volltextzugriff (PDF)

Successful ongoing retreatment with glecaprevir/pibrentasvir + sofosbuvir + ribavirin in a patient with HCV genotype 3 who failed glecaprevir/pibrentasvir with both NS3 and NS5A resistance

Clinical microbiology and infection, 2020-09, Vol.26 (9), p.1266-1268

2020

Volltextzugriff (PDF)

Safety of nevirapine‐containing antiretroviral triple therapy regimens to prevent vertical transmission in an African cohort of HIV‐1‐infected pregnant women

HIV medicine, 2006-07, Vol.7 (5), p.338-344

2006

Volltextzugriff (PDF)

Non-B HIV type 1 subtypes among men who have sex with men in Rome, Italy

AIDS research and human retroviruses, 2009-02, Vol.25 (2), p.157-164

2009

Volltextzugriff (PDF)

1 – 25 von 456

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(433)
Mit Volltextzugriff
(404)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Hepatitis C Virus Genetic Variability and the Presence of NS5B Resistance-Associated Mutations as Natural Polymorphisms in Selected Genotypes Could Affect the Response to NS5B Inhibitors

Two‐drug vs. three‐drug combinations for HIV‐1: Do we have enough data to make the switch?

Alarming rates of virological failure and HIV‐1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY‐study in Cameroon

The Management of Geriatric and Frail HIV Patients. A 2017 Update from the Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic Clinical Management of HIV-1 Infected Persons

Managing Haemophilia for Life: 4th Haemophilia Global Summit

Exploring nasopharyngeal microbiota profile in children affected by SARS-CoV-2 infection

Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice

Natural polymorphisms of HIV-1 subtype-C integrase coding region in a large group of ARV-naïve infected individuals

The use of human immunodeficiency virus resistance tests in clinical practice

Antiretrovirus Activity of a Novel Class of Acyclic Pyrimidine Nucleoside Phosphonates

Prediction of response to antiretroviral therapy by human experts and by the EuResist data‐driven expert system (the EVE study)

Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon

Efficacy of etravirine combined with darunavir or other ritonavir‐boosted protease inhibitors in HIV‐1‐infected patients: an observational study using pooled European cohort data

Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper

Human Immunodeficiency Virus-1 Viral Load Is Elevated in Individuals With Reverse-Transcriptase Mutation M184V/I During Virological Failure of First-Line Antiretroviral Therapy and Is Associated With Compensatory Mutation L74I

Virological response and resistance profile in HIV‐1‐infected patients starting darunavir‐containing regimens

Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs

Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individuals

Relative Potency of Protease Inhibitors in Monocytes/Macrophages Acutely and Chronically Infected with Human Immunodeficiency Virus

HIV MDR is still a relevant issue despite its dramatic drop over the years

Mechanism of Anti-HIV Action of Masked Alaninyl d4T-Mp Derivatives

1,2,3-Triazole-[2,5-Bis-O-(tert-butyldimethylsilyl)-.beta.-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole 2'',2''-dioxide) (TSAO) Analogs: Synthesis and Anti-HIV-1 Activity

Successful ongoing retreatment with glecaprevir/pibrentasvir + sofosbuvir + ribavirin in a patient with HCV genotype 3 who failed glecaprevir/pibrentasvir with both NS3 and NS5A resistance

Safety of nevirapine‐containing antiretroviral triple therapy regimens to prevent vertical transmission in an African cohort of HIV‐1‐infected pregnant women

Non-B HIV type 1 subtypes among men who have sex with men in Rome, Italy

Suchergebnisse filtern